FGF21 has diverse metabolic effects that are beneficial for managing obesity, increasing fatty acid oxidation in the liver, and improving insulin sensitivity in obese individuals [49, 50]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.